Tresch D D, Berkompas D
Department of Cardiology and Geriatrics/Gerontology, Medical College of Wisconsin, Milwaukee 53226, USA.
Cleve Clin J Med. 1995 May-Jun;62(3):156-62. doi: 10.3949/ccjm.62.3.156.
Thrombolysis and other new therapies have proved beneficial in elderly patients with myocardial infarction, but are underused in this age group. Because elderly patients are at greater cardiac risk than younger patients, they have more to gain from treatment. However, these treatments may pose more risk for elderly patients. Physicians must constantly assess the elderly patient's risk status and make treatment decisions based on risk-benefit analysis.
溶栓及其他新疗法已被证明对老年心肌梗死患者有益，但在这个年龄组中未得到充分利用。由于老年患者比年轻患者面临更大的心脏风险，他们从治疗中获益更多。然而，这些治疗可能给老年患者带来更多风险。医生必须不断评估老年患者的风险状况，并基于风险效益分析做出治疗决策。
